Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-74.47%
operating margin TTM
-73.11%
revenue TTM
278.81 Million
revenue per share TTM
5.72$
valuation ratios | |
|---|---|
| pe ratio | -17.23 |
| peg ratio | -2.16 |
| price to book ratio | 86.78 |
| price to sales ratio | 13.06 |
| enterprise value multiple | -18.78 |
| price fair value | 86.78 |
profitability ratios | |
|---|---|
| gross profit margin | 90.89% |
| operating profit margin | -73.11% |
| pretax profit margin | -74.45% |
| net profit margin | -74.47% |
| return on assets | -50.52% |
| return on equity | -289.53% |
| return on capital employed | -83.33% |
liquidity ratio | |
|---|---|
| current ratio | 2.11 |
| quick ratio | 2.04 |
| cash ratio | 1.37 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 163.44 |
| operating cycle | 297.82 |
| days of payables outstanding | 747.96 |
| cash conversion cycle | -450.14 |
| receivables turnover | 2.72 |
| payables turnover | 0.49 |
| inventory turnover | 2.23 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.34 |
| debt equity ratio | 3.38 |
| long term debt to capitalization | 0.76 |
| total debt to capitalization | 0.77 |
| interest coverage | -42.92 |
| cash flow to debt ratio | -0.67 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.68 |
| cash per share | 6.58 |
| operating cash flow per share | -2.68 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.67 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -4,280.33 |
Frequently Asked Questions
When was the last time Axsome Therapeutics, Inc. (NASDAQ:AXSM) reported earnings?
Axsome Therapeutics, Inc. (AXSM) published its most recent earnings results on 12-11-2024.
What is Axsome Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Axsome Therapeutics, Inc. (NASDAQ:AXSM)'s trailing twelve months ROE is -289.53%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Axsome Therapeutics, Inc. (AXSM) currently has a ROA of -50.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AXSM's net profit margin stand at?
AXSM reported a profit margin of -74.47% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AXSM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.11 in the most recent quarter. The quick ratio stood at 2.04, with a Debt/Eq ratio of 3.38.